A detailed history of Eventide Asset Management, LLC transactions in Glaukos Corp stock. As of the latest transaction made, Eventide Asset Management, LLC holds 289,275 shares of GKOS stock, worth $26 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares
289,275
Previous 220,740 31.05%
Holding current value
$26 Million
Previous $22.8 Million 3.46%
% of portfolio
0.43%
Previous 0.43%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$79.92 - $106.55 $5.48 Million - $7.3 Million
68,535 Added 31.05%
289,275 $23.6 Million
Q2 2025

Aug 14, 2025

SELL
$82.27 - $103.29 $5.77 Million - $7.25 Million
-70,181 Reduced 24.12%
220,740 $22.8 Million
Q1 2025

May 15, 2025

BUY
$96.6 - $161.22 $28.1 Million - $46.9 Million
290,921 New
290,921 $28.6 Million
Q2 2024

Aug 13, 2024

BUY
$89.48 - $118.35 $5.69 Million - $7.52 Million
63,542 New
63,542 $7.52 Million

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $4.29B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Eventide Asset Management, LLC Portfolio

Follow Eventide Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eventide Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eventide Asset Management, LLC with notifications on news.